BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9686766)

  • 1. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT; Goetz CG
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
    Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
    Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.
    Martínez-Martín P; Gil-Nagel A; Gracia LM; Gómez JB; Martínez-Sarriés J; Bermejo F
    Mov Disord; 1994 Jan; 9(1):76-83. PubMed ID: 8139608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.
    van Hilten JJ; van der Zwan AD; Zwinderman AH; Roos RA
    Mov Disord; 1994 Jan; 9(1):84-8. PubMed ID: 8139609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
    Louis ED; Lynch T; Marder K; Fahn S
    Mov Disord; 1996 Mar; 11(2):185-92. PubMed ID: 8684390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD).
    Martínez-Martín P; Forjaz MJ; Cubo E; Frades B; de Pedro Cuesta J;
    Mov Disord; 2006 Feb; 21(2):208-14. PubMed ID: 16161158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P; Oakes D; Cui L
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
    Kroonenberg PM; Oort FJ; Stebbins GT; Leurgans SE; Cubo E; Goetz CG
    BMC Med Res Methodol; 2006 Jun; 6():26. PubMed ID: 16772027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
    Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
    Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.
    Forjaz MJ; Martinez-Martin P
    Mov Disord; 2006 Nov; 21(11):1892-8. PubMed ID: 16958134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision.
    Martinez-Martin P; Forjaz MJ
    Mov Disord; 2006 Aug; 21(8):1182-8. PubMed ID: 16673397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the structure of motor symptoms of Parkinson's disease.
    Stochl J; Boomsma A; Ruzicka E; Brozova H; Blahus P
    Mov Disord; 2008 Jul; 23(9):1307-12. PubMed ID: 18464275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination.
    Richards M; Marder K; Cote L; Mayeux R
    Mov Disord; 1994 Jan; 9(1):89-91. PubMed ID: 8139610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.
    Song J; Fisher BE; Petzinger G; Wu A; Gordon J; Salem GJ
    Neurorehabil Neural Repair; 2009 Sep; 23(7):657-61. PubMed ID: 19336530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses.
    Louis ED; Levy G; Côte LJ; Mejia H; Fahn S; Marder K
    Mov Disord; 2002 May; 17(3):513-7. PubMed ID: 12112199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
    Rabey JM; Bass H; Bonuccelli U; Brooks D; Klotz P; Korczyn AD; Kraus P; Martinez-Martin P; Morrish P; Van Sauten W; Van Hilten B
    Clin Neuropharmacol; 1997 Aug; 20(4):322-37. PubMed ID: 9260730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease.
    Weisscher N; Post B; de Haan RJ; Glas CA; Speelman JD; Vermeulen M
    Neurology; 2007 Dec; 69(23):2155-61. PubMed ID: 18056579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.